The Lancet Haematology in conversation with
Lan-Lan Smith, Editor-in-Chief, Cheryl Lai, Acting Deputy Editor, and Emma Cookson, Senior Editor at The Lancet Haematology, in conversation with the journal’s authors, explore their latest research and its impact on people’s health, healthcare, and health policy.
A monthly audio companion to the journal, this podcast covers a broad range of topics, from racial and ethnic disparities in leukaemia survival outcomes to resuscitation with blood products compared with saline, the link between mental health and lymphoma to haemolytic disease in newborns, and more.
- Update frequency
- every 44 days
- Average duration
- 15 minutes
- Episodes
- 59
- Years Active
- 2014 - 2025
Dr Judith Boer on lymphoblastic leukaemia in children
Editor-in-Chief, Dr Lan-Lan Smith, speaks with Dr Judith Boer (Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands) about outcome of ABL-class acute lymphoblastic leukaemia in chi…
Imatinib for paediatric leukaemia
Andrea Biondi joins The Lancet Haematology to discuss his work on imatinib as a treatment for paediatric Philadelphia chromosome-positive acute lymphoblastic leukaemia.
Continue this conversation on s…
Predicting the risk of adenoviraemia
Prashant Hiwarkar joins The Lancet Haematology to discuss his new paper, an investigation into whether serial faecal PCR monitoring can predict the risk of adenoviraemia and survival outcomes after H…
Adverse events in haematological malignancies
Lead author Gita Thanarajasingam joins The Lancet Haematology to discuss the new Commission on assessment and adverse event reporting in haematological malignancies.
Continue this conversation on soci…
EPO blood doping and cycling: The Lancet Haematology: June 29, 2017
Jules Heuberger talks about his study on the effectiveness of EPO use by cyclists.
Continue this conversation on social!
Follow us today at...
https://thelancet.bsky.social/
https://instagram.com/thelanc…
Trauma-induced coagulopathy: The Lancet Haematology: June issue
Petra Innerhofer discusses reversal of trauma-induced coagulopathy using first-line coagulation factor concentrates or fresh frozen plasma.
Continue this conversation on social!
Follow us today at...
ht…
Childhood leukaemia survival (CONCORD-2): The Lancet Haematology: April 11, 2017
Audrey Bonaventure discusses her CONCORD-2 study, monitoring survival trends of two types of childhood leukaemia in 53 countries between 1995 and 2009.
Continue this conversation on social!
Follow us t…
Superficial-vein thrombosis: The Lancet Haematology: February 15 2017
Jan Beyer discusses the SURPRISE trial of patients developing complications from superficial-vein thrombosis.
Continue this conversation on social!
Follow us today at...
https://thelancet.bsky.social/
ht…
Economic burden of blood disorders in Europe: The Lancet Haematology: July 21, 2016
Dr Jose Leal discusses a study of the costs related to malignant and non-malignant blood disorders in Europe in 2012.
Continue this conversation on social!
Follow us today at...
https://thelancet.bsky.s…
Castleman disease: The Lancet Haematology: March 17, 2016
David Fajgenbaum discusses a literature review to raise awareness of idiopathic multicentric Castleman disease, a poorly understood haematological disorder.
Continue this conversation on social!
Follow…
Deep-vein thrombosis: The Lancet Haematology, October 29, 2015
Walter Ageno discusses the use of an algorithm combining limited and whole-leg compression ultrasonography to diagnose deep-vein thrombosis.
Continue this conversation on social!
Follow us today at...
h…
Financial toxicity: The Lancet Haematology: September 17, 2015
Scott Huntington discusses the financial toxicity of oncology treatments
Continue this conversation on social!
Follow us today at...
https://thelancet.bsky.social/
https://instagram.com/thelancetgroup
htt…
Idiopathic thrombocytopenic purpura: The Lancet Haematology: July 29, 2015
James Bussel discusses a study looking at treatment options for children facing idiopathic thrombocytopenic purpura.
Continue this conversation on social!
Follow us today at...
https://thelancet.bsky.so…
INWORKS: The Lancet Haematology: June 29, 2015
Klervi Leuraud discusses a study reporting on the risk of developing leukaemia and lymphoma in workers monitored for radiation exposure.
Continue this conversation on social!
Follow us today at...
https…
Warfarin: The Lancet Haematology: May 26, 2015
Páll Önundarson describes a new method for monitoring clotting in patients treated with warfarin, which they tested in a non-inferiority, randomised clinical trial.
Continue this conversation on socia…
Atrial fibrillation and NOACs: The Lancet Haematology: April 2, 2015
Mahmoud Zureik discusses risk of bleeding in patients with non-valvular atrial fibrillation who switched and those who remained on a vitamin K antagonist.
Continue this conversation on social!
Follow u…
1 million stem cells: The Lancet Haematology: February 27, 2015
Dietger Niederwieser and Richard Lane discuss the journey to 1 million haematopoietic stem cell transplantations.
Continue this conversation on social!
Follow us today at...
https://thelancet.bsky.socia…
The Lancet Haematology: January 7, 2015
Guillermo Garcia-Manero discusses a phase 1/2 study on sequential azacitidine and lenalidomide in high-risk MDS and AML.
Continue this conversation on social!
Follow us today at...
https://thelancet.bsk…
The Lancet Haematology: December 1, 2014
Gregory Kato discusses a phase I study for the treatment of leg ulcers for people with sickle-cell disease.
Continue this conversation on social!
Follow us today at...
https://thelancet.bsky.social/
http…